临产孕妇凝血指标检测的临床意义

Clinical significance of coagulation testing in labor pregnant women

目的探讨临产孕妇凝血指标的变化特征,为预防产后出血提供科学依据。方法选取2014年5月—2015年5月商丘市妇幼保健院妇产科收治的临产孕妇230例,设为观察组,另随机抽取230例未孕妇女作为对照组,分析两组凝血指标的变化。结果与对照组相比,观察组凝血活酶时间(APTT)、凝血酶原时间(PT)明显降低,而纤维蛋白原(FIB)、纤维蛋白原降解产物(FDP)的指标明显升高,且差异有统计学意义(P<0.05);两组凝血酶时间(TT)的检测结果差异无统计学意义(P>0.05)。结论及时对临产孕妇进行凝血功能检测,可预防产妇产后并发症的发生,降低病死率,对保护母婴健康有重要的临床意义。

Objective To investigate the changes in labor pregnant coagulation characteristics, provide a scientific basis for the prevention of postpartum hemorrhage. Methods From May 2014 to May 2015 pregnant women at Shangqiu City MCH treated 230 cases of obstetrics and gynecology, observation group, another 230 cases were randomly selected non - pregnant women as a control group, two groups were analyzed for coagulation Variety. Results Compared with the control group, the observation group AP3T, PT was significantly reduced, and FIB, FDP index significantly increased, and the difference was statistically significant （ P 〈 0. 05 ） ; TT test results between the two groups was not statistically significant （ P 〉 0. 05 ）. Conclusion The timely detection of coagulation of pregnant women in labor can prevent postpartum complications and reduce mortality, to protect maternal and child health has important clinical significance.